BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ding H, Liu J, Wang C, Su Y. NONO promotes hepatocellular carcinoma progression by enhancing fatty acids biosynthesis through interacting with ACLY mRNA. Cancer Cell Int 2020;20:425. [PMID: 32884448 DOI: 10.1186/s12935-020-01520-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gu C, Shi X, Dai C, Shen F, Rocco G, Chen J, Huang Z, Chen C, He C, Huang T, Chen C. RNA m6A Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications. The Innovation 2020;1:100066. [DOI: 10.1016/j.xinn.2020.100066] [Cited by in Crossref: 24] [Cited by in F6Publishing: 2] [Article Influence: 12.0] [Reference Citation Analysis]
2 Paul B, Lewinska M, Andersen JB. Lipid alterations in chronic liver disease and liver cancer. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100479] [Reference Citation Analysis]
3 Razpotnik R, Nassib P, Kunej T, Rozman D, Režen T. Identification of Novel RNA Binding Proteins Influencing Circular RNA Expression in Hepatocellular Carcinoma. Int J Mol Sci 2021;22:7477. [PMID: 34299096 DOI: 10.3390/ijms22147477] [Reference Citation Analysis]
4 Icard P, Simula L, Wu Z, Berzan D, Sogni P, Dohan A, Dautry R, Coquerel A, Lincet H, Loi M, Fuks D. Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma? Drug Resist Updat 2021;:100790. [PMID: 34924279 DOI: 10.1016/j.drup.2021.100790] [Reference Citation Analysis]